O	0	9	Comparing
O	10	12	an
B-intervention	13	18	olive
I-intervention	19	22	oil
I-intervention	22	23	-
I-intervention	23	31	enriched
I-intervention	32	36	diet
O	37	39	to
O	40	41	a
B-control	42	50	standard
I-control	51	56	lower
I-control	56	57	-
I-control	57	60	fat
I-control	61	65	diet
O	66	69	for
O	70	76	weight
O	77	81	loss
O	82	84	in
O	85	91	breast
O	92	98	cancer
O	99	108	survivors
O	108	109	:
O	110	111	a
O	112	117	pilot
O	118	123	study
O	123	124	.

O	125	136	Traditional
O	137	142	diets
O	143	147	that
O	148	155	include
O	156	164	moderate
O	165	167	to
O	168	172	high
O	173	180	intakes
O	181	183	of
O	184	189	extra
O	190	196	virgin
O	197	202	olive
O	203	206	oil
O	207	211	have
O	212	216	been
O	217	224	related
O	225	227	to
O	228	229	a
O	230	238	decrease
O	239	241	in
O	242	248	breast
O	249	255	cancer
O	256	260	risk
O	260	261	.

O	262	264	We
O	265	277	hypothesized
O	278	282	that
O	283	285	an
O	286	291	olive
O	292	295	oil
O	295	296	-
O	296	304	enriched
O	305	309	diet
O	310	315	would
O	316	320	lead
O	321	323	to
O	324	331	greater
O	332	338	weight
O	339	343	loss
O	344	347	and
O	348	358	acceptance
O	358	359	,
O	360	368	compared
O	369	373	with
O	374	375	a
O	376	384	standard
O	385	389	diet
O	389	390	,
O	391	393	in
B-eligibility	394	399	women
I-eligibility	400	410	previously
I-eligibility	411	420	diagnosed
I-eligibility	421	425	with
I-eligibility	426	434	invasive
I-eligibility	435	441	breast
I-eligibility	442	448	cancer
O	448	449	.

O	450	462	Participants
O	463	471	consumed
O	472	473	a
O	474	482	National
O	483	489	Cancer
O	490	499	Institute
O	500	501	(
O	501	504	NCI
O	504	505	)
O	506	510	diet
O	511	512	(
O	512	517	total
O	518	521	fat
O	522	523	>
O	524	526	15
O	526	527	%
O	528	531	and
O	532	533	<
O	534	536	30
O	536	537	%
O	537	538	)
O	539	542	and
O	543	544	a
O	545	550	plant
O	550	551	-
O	551	556	based
O	557	562	olive
O	563	566	oil
O	567	571	diet
O	572	573	(
O	573	577	PBOO
O	577	578	;
O	579	580	>
O	581	583	or
O	584	585	=
O	586	587	3
O	588	599	tablespoons
O	600	602	of
O	603	608	olive
O	609	612	oil
O	612	613	/
O	613	616	day
O	616	617	)
O	618	621	for
O	622	623	8
O	624	629	weeks
O	629	630	,
O	631	635	each
O	636	640	with
O	641	647	random
O	648	658	assignment
O	659	661	to
O	662	665	the
O	666	671	order
O	671	672	.

O	673	675	We
O	676	687	established
O	688	689	a
O	690	696	weight
O	697	701	loss
O	702	706	goal
O	707	709	of
O	710	712	at
O	713	718	least
O	719	720	5
O	720	721	%
O	722	724	of
O	725	733	baseline
O	734	740	weight
O	740	741	.

O	742	747	After
O	748	758	completion
O	759	761	of
O	762	765	the
O	766	769	two
O	770	774	diet
O	775	781	trials
O	781	782	,
O	783	787	each
O	788	799	participant
O	800	804	self
O	804	805	-
O	805	813	selected
O	814	817	one
O	818	820	of
O	821	824	the
O	825	830	diets
O	831	834	for
O	835	837	an
O	838	848	additional
O	849	850	6
O	851	857	months
O	858	860	of
O	861	867	follow
O	867	868	-
O	868	870	up
O	871	874	for
O	875	881	weight
O	882	892	management
O	892	893	.

O	894	898	Body
O	899	907	measures
O	908	912	were
O	913	917	done
O	918	924	before
O	925	928	and
O	929	934	after
O	935	939	each
O	940	944	diet
O	945	948	and
O	949	954	after
O	955	961	follow
O	961	962	-
O	962	964	up
O	964	965	;
O	966	973	fasting
O	974	979	blood
O	980	987	samples
O	988	992	were
O	993	1002	collected
O	1003	1008	after
O	1009	1013	each
O	1014	1018	diet
O	1019	1022	and
O	1023	1028	after
O	1029	1035	follow
O	1035	1036	-
O	1036	1038	up
O	1038	1039	.

B-total-participants	1040	1045	Forty
I-total-participants	1045	1046	-
I-total-participants	1046	1050	four
O	1051	1061	overweight
O	1062	1067	women
O	1068	1075	started
O	1076	1079	and
B-total-participants	1080	1082	28
O	1083	1092	completed
O	1093	1096	the
O	1097	1099	44
O	1099	1100	-
O	1100	1104	week
O	1105	1113	protocol
O	1113	1114	.

B-iv-bin-abs	1115	1121	Twelve
O	1122	1123	(
B-iv-bin-percent	1123	1125	80
I-iv-bin-percent	1125	1126	%
O	1126	1127	)
O	1128	1130	of
O	1131	1134	the
B-intervention-participants	1135	1137	15
O	1138	1143	women
O	1144	1147	who
O	1148	1155	started
O	1156	1160	with
O	1161	1164	the
O	1165	1169	PBOO
O	1170	1174	diet
B-outcome	1175	1183	achieved
I-outcome	1184	1185	a
I-outcome	1186	1192	weight
I-outcome	1193	1197	loss
I-outcome	1198	1200	of
I-outcome	1201	1202	>
I-outcome	1203	1205	or
I-outcome	1206	1207	=
I-outcome	1208	1209	5
I-outcome	1209	1210	%
O	1211	1219	compared
O	1220	1222	to
B-cv-bin-abs	1223	1224	4
O	1225	1226	(
B-cv-bin-percent	1226	1228	31
I-cv-bin-percent	1228	1229	%
O	1229	1230	)
O	1231	1233	of
O	1234	1237	the
B-control-participants	1238	1240	13
O	1241	1244	who
O	1245	1252	started
O	1253	1257	with
O	1258	1261	the
O	1262	1265	NCI
O	1266	1270	diet
O	1271	1272	(
O	1272	1273	p
O	1274	1275	<
O	1276	1277	0
O	1277	1278	.
O	1278	1280	01
O	1280	1281	)
O	1281	1282	.

O	1283	1291	Nineteen
O	1292	1294	of
O	1295	1298	the
O	1299	1301	22
O	1302	1307	women
O	1308	1316	eligible
O	1317	1320	for
O	1321	1327	follow
O	1327	1328	-
O	1328	1330	up
O	1331	1336	chose
O	1337	1340	the
O	1341	1345	PBOO
O	1346	1350	diet
O	1350	1351	,
O	1352	1355	and
O	1356	1359	all
O	1360	1369	completed
O	1370	1373	the
O	1374	1379	study
O	1379	1380	.

O	1381	1383	Of
O	1384	1387	the
O	1388	1389	3
O	1390	1395	women
O	1396	1399	who
O	1400	1405	chose
O	1406	1409	the
O	1410	1413	NCI
O	1414	1418	diet
O	1419	1422	for
O	1423	1429	follow
O	1429	1430	-
O	1430	1432	up
O	1432	1433	,
O	1434	1435	1
O	1436	1445	completed
O	1446	1449	the
O	1450	1455	study
O	1455	1456	.

O	1457	1460	The
O	1461	1465	PBOO
O	1466	1470	diet
O	1471	1479	resulted
O	1480	1482	in
O	1483	1488	lower
B-outcome	1489	1502	triglycerides
O	1503	1504	(
O	1504	1507	NCI
B-cv-cont-mean	1508	1511	105
O	1512	1513	+
O	1513	1514	/
O	1514	1515	-
B-cv-cont-sd	1516	1518	46
I-cv-cont-sd	1519	1521	mg
I-cv-cont-sd	1521	1522	/
I-cv-cont-sd	1522	1524	dL
O	1524	1525	,
O	1526	1530	PBOO
B-iv-cont-mean	1531	1533	96
O	1534	1535	+
O	1535	1536	/
O	1536	1537	-
B-iv-cont-sd	1538	1540	37
I-iv-cont-sd	1541	1543	mg
I-iv-cont-sd	1543	1544	/
I-iv-cont-sd	1544	1546	dL
O	1546	1547	,
O	1548	1549	p
O	1550	1551	=
O	1552	1553	0
O	1553	1554	.
O	1554	1556	06
O	1556	1557	)
O	1558	1561	and
B-outcome	1562	1568	higher
I-outcome	1569	1573	high
I-outcome	1573	1574	-
I-outcome	1574	1581	density
I-outcome	1582	1593	lipoprotein
I-outcome	1594	1605	cholesterol
O	1606	1607	(
O	1607	1610	HDL
O	1610	1611	-
O	1611	1612	C
O	1612	1613	)
O	1614	1615	(
O	1615	1618	NCI
B-cv-cont-mean	1619	1621	64
O	1622	1623	+
O	1623	1624	/
O	1624	1625	-
B-cv-cont-sd	1626	1628	13
I-cv-cont-sd	1629	1631	mg
I-cv-cont-sd	1631	1632	/
I-cv-cont-sd	1632	1634	dL
O	1634	1635	,
O	1636	1640	PBOO
B-iv-cont-mean	1641	1643	68
O	1644	1645	+
O	1645	1646	/
O	1646	1647	-
B-iv-cont-sd	1648	1650	12
I-iv-cont-sd	1651	1653	mg
I-iv-cont-sd	1653	1654	/
I-iv-cont-sd	1654	1656	dL
O	1656	1657	,
O	1658	1659	p
O	1660	1661	=
O	1662	1663	0
O	1663	1664	.
O	1664	1667	001
O	1667	1668	)
O	1668	1669	.

O	1670	1672	An
O	1673	1678	olive
O	1679	1682	oil
O	1682	1683	-
O	1683	1691	enriched
O	1692	1696	diet
O	1697	1704	brought
O	1705	1710	about
O	1711	1718	greater
B-outcome	1719	1725	weight
I-outcome	1726	1730	loss
O	1731	1735	than
O	1736	1737	a
O	1738	1743	lower
O	1743	1744	-
O	1744	1747	fat
O	1748	1752	diet
O	1753	1755	in
O	1756	1758	an
O	1759	1760	8
O	1760	1761	-
O	1761	1765	week
O	1766	1776	comparison
O	1776	1777	.

O	1778	1786	Moreover
O	1786	1787	,
O	1788	1793	these
O	1794	1799	women
O	1800	1805	chose
O	1805	1806	,
O	1807	1821	overwhelmingly
O	1821	1822	,
O	1823	1826	the
O	1827	1832	olive
O	1833	1836	oil
O	1836	1837	-
O	1837	1845	enriched
O	1846	1850	diet
O	1851	1854	for
O	1855	1856	6
O	1857	1863	months
O	1864	1866	of
O	1867	1873	follow
O	1873	1874	-
O	1874	1876	up
O	1876	1877	.

O	1878	1880	An
O	1881	1886	olive
O	1887	1890	oil
O	1890	1891	-
O	1891	1899	enriched
O	1900	1904	diet
O	1905	1908	may
O	1909	1911	be
O	1912	1916	more
O	1917	1928	efficacious
O	1929	1932	for
O	1933	1939	weight
O	1940	1944	loss
O	1945	1947	in
O	1948	1954	breast
O	1955	1961	cancer
O	1962	1971	survivors
O	1972	1976	than
O	1977	1978	a
O	1979	1987	standard
O	1988	1993	lower
O	1993	1994	-
O	1994	1997	fat
O	1998	2002	diet
O	2002	2003	.
